Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan G Zaroff

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|December 19, 2008
Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformationHelen Kim, Pirro G Hysi, Ludmila Pawlikowska, et al.
Neurosurgery|November 8, 2007
Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatmentAchal S Achrol, Helen Kim, Ludmila Pawlikowska, et al.
Journal of the American College of Cardiology|October 2, 2019
Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation: The COAPT TrialFederico M Asch, Paul A Grayburn, Robert J Siegel, et al.
Plos One|October 8, 2013
A genome-wide investigation of copy number variation in patients with sporadic brain arteriovenous malformationNasrine Bendjilali, Helen Kim, Shantel Weinsheimer, et al.
Stroke|December 3, 2005
Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformationsAchal S Achrol, Ludmila Pawlikowska, Charles E McCulloch, et al.
European Journal of Heart Failure|February 24, 2023
Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPT trialKent Y Feng, Andrew P Ambrosy, Zhipeng Zhou, et al.
Neurosurgery|April 28, 2006
Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformationsLudmila Pawlikowska, K Y Trudy Poon, Achal S Achrol, et al.
American Heart Journal|August 8, 2023
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE projectMatthew D Solomon, Grace Tabada, Sue Hee Sung, et al.
Structural Heart : the Journal of the Heart Team|March 14, 2024
Eligibility and Potential Benefit of Transcatheter Edge-to-Edge Repair in a Contemporary Cohort With Heart Failure: Evidence From a Large Integrated Health Care Delivery SystemAndrew P Ambrosy, Jingrong Yang, Andrew S Tai, et al.
Journal of the American Heart Association|July 8, 2023
Incidence, Predictors, and Outcomes Associated With Worsening Renal Function in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT TrialJeremy Kong, Jonathan G Zaroff, Andrew P Ambrosy, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Cerebrovascular Diseases (Basel, Switzerland)|December 19, 2008
Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformationHelen Kim, Pirro G Hysi, Ludmila Pawlikowska, et al.
Neurosurgery|November 8, 2007
Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatmentAchal S Achrol, Helen Kim, Ludmila Pawlikowska, et al.
Journal of the American College of Cardiology|October 2, 2019
Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation: The COAPT TrialFederico M Asch, Paul A Grayburn, Robert J Siegel, et al.
Plos One|October 8, 2013
A genome-wide investigation of copy number variation in patients with sporadic brain arteriovenous malformationNasrine Bendjilali, Helen Kim, Shantel Weinsheimer, et al.
Stroke|December 3, 2005
Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformationsAchal S Achrol, Ludmila Pawlikowska, Charles E McCulloch, et al.
European Journal of Heart Failure|February 24, 2023
Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPT trialKent Y Feng, Andrew P Ambrosy, Zhipeng Zhou, et al.
Neurosurgery|April 28, 2006
Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformationsLudmila Pawlikowska, K Y Trudy Poon, Achal S Achrol, et al.
American Heart Journal|August 8, 2023
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE projectMatthew D Solomon, Grace Tabada, Sue Hee Sung, et al.
Structural Heart : the Journal of the Heart Team|March 14, 2024
Eligibility and Potential Benefit of Transcatheter Edge-to-Edge Repair in a Contemporary Cohort With Heart Failure: Evidence From a Large Integrated Health Care Delivery SystemAndrew P Ambrosy, Jingrong Yang, Andrew S Tai, et al.
Journal of the American Heart Association|July 8, 2023
Incidence, Predictors, and Outcomes Associated With Worsening Renal Function in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT TrialJeremy Kong, Jonathan G Zaroff, Andrew P Ambrosy, et al.
Pageof 7